MKI67 and cancer: Furthermore, immunohistochemical staining for the proliferation marker Ki67 on xenograft tumors (Fig 7B and 7D) showed sAPRIL-BP significantly inhibited cancer cell proliferation in vivo in a dose-dependent manner.